118 related articles for article (PubMed ID: 19215791)
41. Japanese late-onset breast cancer families: Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations.
Okumura T; Fukutomi T; Tsuda H; Kanai Y; Ushijima T; Akashi-Tanaka S; Nanasawa T
Breast Cancer; 1998; 5(3):251-4. PubMed ID: 18841336
[TBL] [Abstract][Full Text] [Related]
42. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
43. Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.
Brunelli M; Manfrin E; Martignoni G; Miller K; Remo A; Reghellin D; Bersani S; Gobbo S; Eccher A; Chilosi M; Bonetti F
Am J Clin Pathol; 2009 May; 131(5):678-82. PubMed ID: 19369627
[TBL] [Abstract][Full Text] [Related]
44. Multicentric glioblastoma multiforme in a patient with BRCA-1 invasive breast cancer.
Elmariah SB; Huse J; Mason B; Leroux P; Lustig RA
Breast J; 2006; 12(5):470-4. PubMed ID: 16958968
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.
Jaworowska E; Tarnowska C; Lubiński J; Serrano-Fernández P; Huzarski T; Górski B; Masojć B; Jakubiszyn J; Korytowska A; Kram A; Rabczynski J; Lubiński J
Anticancer Res; 2009 Jul; 29(7):2703-5. PubMed ID: 19596949
[TBL] [Abstract][Full Text] [Related]
47. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM
Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742
[TBL] [Abstract][Full Text] [Related]
48. The phases of disclosing BRCA1/2 genetic information to offspring.
Clarke S; Butler K; Esplen MJ
Psychooncology; 2008 Aug; 17(8):797-803. PubMed ID: 18646247
[TBL] [Abstract][Full Text] [Related]
49. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
[TBL] [Abstract][Full Text] [Related]
50. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
51. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
Meng J; Shi YR; Niu RF; Fu L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
[TBL] [Abstract][Full Text] [Related]
52. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
53. Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer.
Bertolo C; Guerrero D; Vicente F; Cordoba A; Esteller M; Ropero S; Guillen-Grima F; Martinez-Peñuela JM; Lera JM
Am J Clin Pathol; 2008 Sep; 130(3):414-24. PubMed ID: 18701415
[TBL] [Abstract][Full Text] [Related]
54. Application of a new classification to a breast tumor series from a population-based cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004 .
Zarcone M; Amodio R; Campisi I; Cusimano R; Dolcemascolo C; Miceli V; Traina A; Macaluso M
Ann N Y Acad Sci; 2009 Feb; 1155():222-6. PubMed ID: 19250207
[TBL] [Abstract][Full Text] [Related]
55. Hereditary breast cancer: from bench to bedside.
De Grève J; Sermijn E; De Brakeleer S; Ren Z; Teugels E
Curr Opin Oncol; 2008 Nov; 20(6):605-13. PubMed ID: 18841041
[TBL] [Abstract][Full Text] [Related]
56. Genetic testing, adverse selection, and the demand for life insurance.
Zick CD; Smith KR; Mayer RN; Botkin JR
Am J Med Genet; 2000 Jul; 93(1):29-39. PubMed ID: 10861679
[TBL] [Abstract][Full Text] [Related]
57. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
Cypowyj C; Eisinger F; Huiart L; Sobol H; Morin M; Julian-Reynier C
Psychooncology; 2009 Feb; 18(2):209-15. PubMed ID: 19061202
[TBL] [Abstract][Full Text] [Related]
58. BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer.
Breuer A; Kandel M; Fisseler-Eckhoff A; Sutter C; Schwaab E; Lück HJ; du Bois A
Onkologie; 2007 Jun; 30(6):316-8. PubMed ID: 17551255
[TBL] [Abstract][Full Text] [Related]
59. Morphological predictors of BRCA1 germline mutations in young women with breast cancer.
Southey MC; Ramus SJ; Dowty JG; Smith LD; Tesoriero AA; Wong EE; Dite GS; Jenkins MA; Byrnes GB; Winship I; Phillips KA; Giles GG; Hopper JL
Br J Cancer; 2011 Mar; 104(6):903-9. PubMed ID: 21343941
[TBL] [Abstract][Full Text] [Related]
60. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
Tung N; Wang Y; Collins LC; Kaplan J; Li H; Gelman R; Comander AH; Gallagher B; Fetten K; Krag K; Stoeckert KA; Legare RD; Sgroi D; Ryan PD; Garber JE; Schnitt SJ
Breast Cancer Res; 2010; 12(1):R12. PubMed ID: 20149218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]